middle.news
Independent US Study Validates ArtemiC™’s Breakthrough in Viral Inflammation
10:39pm on Friday 29th of August, 2025 AEST
•
Healthcare
Read Story
Independent US Study Validates ArtemiC™’s Breakthrough in Viral Inflammation
10:39pm on Friday 29th of August, 2025 AEST
Key Points
Up to 85% survival improvement in viral inflammatory mouse model
Significant reductions in viral load and cytokine-driven inflammation
ArtemiC™ acts as a nano-formulated immunomodulator without immunosuppression
Study independently funded and conducted by AMC Pharma USA and USF
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
RGT
OPEN ARTICLE